Company / Current Liabilities per Share
SUTRO BIOPHARMA, INC. Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$9.05
FY2025
5-year range
$0.91 / $9.05
FY2021-FY2025
Trend
+318.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +318% YoY in FY2025, a notable deviation from the 7-year average annual change of +41%.
Based on SEC 10-K filings.
9.05 in FY2025 with a 5-year CAGR of +47.8%.
Increased from $1.63 to $9.05 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +84.7%
- 5-Year CAGR
- +47.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- SUTRO BIOPHARMA, INC.'s current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 318.4% year-over-year.
- Peak current liabilities per share was recorded in FY2018.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.05 | +318.4% |
| FY2024 | $2.16 | +32.6% |
| FY2023 | $1.63 | +13.5% |
| FY2022 | $1.44 | +57.5% |
| FY2021 | $0.91 | -28.8% |
| FY2020 | $1.28 | -11.2% |
| FY2019 | $1.44 | -98.2% |
| FY2018 | $78.27 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026